Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1464 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Ipsen S.A.. (2/24/15). "Press Release: Ipsen Enters into Option Agreement to Acquire Canbex Therapeutics". Paris & London. 2015-02-24
Carbios S.A.. (11/2/15). "Press Release: Carbios Receives € 1.6 Million from Bpifrance for Completing the Third Development Stage of the Thanaplast Project". Clermont-Ferrand. 2015-02-11
Inoviem Scientific. (2/10/15). "Press Release: Inoviem Scientific Raises €500,000 ($566,000) in Seed Funding from Cap Innov’Est". Strasbourg. 2015-02-10
Poxel S.A.. (2/5/15). "Press Release: Success of the IPO of Poxel. Almost Full Exercise of the Extension Option – €25.0m Raised on Euronext in Paris – Offer Price Set at €6.66 per Share [not for US, CA, AU, JP or to U.S.persons]". Lyon. 2015-02-05
Valneva S.E.. (2/4/15). "Press Release: Valneva Announces the Successful Completion of Its EUR 45 Million Capital Increase [Not for United States, Canada, Australia or Japan]". Lyon. 2015-02-04
PPF Group N.V.. (2/4/15). "Press Release: PPF Group Acquires a Minority Stake in Biotech Company Cytune Pharma in Cooperation with Sotio". 2015-02-04
Magnisense SE. (2/2/15). "Press Release: Magnisense Receives €1.2 Million in Financing from Bpifrance for Its Innovative MI² Project to Develop Emergency Diagnostic Tests for Cardiovascular Diseases". Paris. 2015-02-02
Genticel S.A.. (2/2/15). "Press Release: Genticel Licenses Vaxiclase Platform to Serum Institute of India for Use in Pertussis Vaccines". Paris & Toulouse. 2015-02-02
Valneva S.E.. (1/29/15). "Press Release: Valneva Grants Exclusive Worldwide License to Immune Targeting Systems for the Development of Hepatitis B Vaccines in Combination with the IC31 Adjuvant". Lyon. 2015-01-29
Bionext. (1/28/15). "Press Release: Bionext Raises €1M in Seed Funding from the Cap Innov'Est Fund and Angel investors". Strasbourg. 2015-01-28
Sartorius AG. (1/27/15). "Press Release: Preliminary Results 2014. Sartorius Stedim Biotech with Strong Growth Across the Entire Product Portfolio and All Regions – Positive Outlook for 2015". 2015-01-27
JEOL Ltd.. (1/27/15). "Press Release: JEOL (Europe) SAS Donates NMR to BIPM". 2015-01-27
bioMérieux S.A.. (1/22/15). "Press Release: bioMérieux and Astute Medical Sign a Global Agreement to Develop and Market NephroCheck Test for VIDAS, an Assay to Assess the Risk of Developing Acute Kidney Injury". Marcy l’Étoile & San Diego, CA. 2015-01-22
bioMérieux S.A.. (1/22/15). "Press Release: Business Review for the Three Months and Full Year Ended December 31, 2014". Marcy l’Étoile. 2015-01-22
Carbios S.A.. (1/20/15). "Press Release: Carbios Appoints Raquel Lizarraga as Head of Investor Relations". Clermont-Ferrand. 2015-01-20
Seventure Partners. (1/20/14). "Press Release: Seventure Partners Launches New €120m »Health For Life Capital« Innovation Fund Dedicated to Life Sciences". Paris. 2015-01-20
MedDay Pharmaceuticals S.A.S.. (1/14/15). "Press Release: MedDay Provides Update on Pipeline Progress". Paris. 2015-01-14
Diaxonhit S.A.. (1/14/15). "Press Release: Diaxonhit Announces the CE Marking of the BJI InoPlex Test and Its Commercial Launch". Paris. 2015-01-14
MedDay Pharmaceuticals S.A.S.. (1/13/15). "Press Release: MedDay Appoints Philippe Goupit to Its Board of Directors". Paris. 2015-01-13
Cellectis S.A.. (1/13/15). "Press Release: Cellectis and Ohio State University, through the Ohio State Innovation Foundation, Enter into Licensing Agreement for Chimeric Antigen Receptor Technology Targeting Multiple Myeloma". Paris. 2015-01-13
Diaxonhit S.A.. (1/12/15). "Press Release: Diaxonhit Announces that Strasbourg University Hospital Will Become its European Central Laboratory for Processing the CareDx AlloMap Heart Transplant Tests". Paris. 2015-01-12
bioMérieux S.A.. (1/9/15). "Press Release: Strategic Alliance between bioMérieux and Copan to Automate Clinical Microbiology Laboratories and Enhance Their Operational Efficiency". Marcy l’Étoile & Brescia. 2015-01-09
Oddo & Cie. (1/7/15). "Press Release: The Completion of the Acquisition of Seydler, Mittelstand Specialist, Transforms the Oddo Group into a Franco-German Player". Paris. 2015-01-07
Cellectis S.A.. (1/6/15). "Press Release: Cellectis Announces the Issuance by the USPTO of a Patent Covering a Seminal Nuclease-based “Gene Editing” Method". Paris. 2015-01-06
Adocia S.A.. (12/19/14). "Press Release: Lilly and Adocia Announce Alliance to Co-develop Ultra-rapid Insulin Based on BioChaperone Technology". Lyon & Indianapolis, IN. 2014-12-19
France Biotech. (12/18/14). "Press Release: France Biotech Presents the Results of Its Twelfth Annual Survey, »Panorama of the Life Sciences«". Paris. 2014-12-18
Ynsect S.A.. (12/17/14). "Press Release: Ynsect Raised 5.5 Million Euros During Its Second Funding Campaign". 2014-12-17
Neovacs S.A.. (12/16/14). "Press Release: Neovacs Announces Top Line Phase IIb Clinical Trial Results of TNF-Kinoid in Rheumatoid Arthritis and Update on Clinical Programs". Paris. 2014-12-16
Carlina Technologies. (12/16/14). "Press Release: Carlina Technologies Signs a Partnership Agreement with Atlangram to Develop Controlled-release Forms of Antibiotics Targeting Osteoarticular Diseases". Angers. 2014-12-16
IntegraGen S.A.. (12/16/14). "Press Release: IntegraGen Collaborating with PICCOLO Study Investigators to Validate Hsa-miR-31-3p Metastatic Colorectal Cancer Biomarker". Evry. 2014-12-16
Curie-Cancer. (12/16/14). "Press Release: Curie-Cancer and GamaMabs Pharma Renew Their Research Partnership to Develop an Antibody for Gynecological Cancers". Paris & Toulouse. 2014-12-16
Biovision (Fondation pour l’Universite de Lyon / Andrew Lloyd & Associates). (12/15/14). "Press Release: Funding Tomorrow’s Life Science Innovators. The 2015 Investor Conference at Biovision". 2014-12-15
Novacyt S.A.. (12/15/14). "Press Release: Transition to Continous Trading". Paris & Cambridge. 2014-12-15
Valneva S.E.. (12/11/14). "Press Release: Valneva and BliNK Therapeutics Announce Launch of New Biotech Company in Innovative Antibody Discovery. New company Has Already Secured First Round of Financing". Louvain-la-Neuve. 2014-12-11
Alizé Pharma S.A.S.. (12/10/14). "Press Release: Alizé Pharma Announces Positive Results for AZP-531, Its Unacylated Ghrelin Analog, from Two Phase I Clinical Trials in Healthy Volunteers and Obese Subjects". Lyon. 2014-12-10
Valneva S.E.. (12/10/14). "Press Release: Valneva Announces Publication of First Phase II Data of Tuberculosis Vaccine Candidate Formulated with IC31® Adjuvant. Clinical Trial in HIV-infected Adults Showed Good Safety and Immunogenicity". Lyon. 2014-12-10
Roche. (12/10/14). "Press Release: Roche’s Preeclampsia Test Helps to Predict this Life-threatening Condition in Pregnant Women at Risk. New Data Demonstrate High Prognostic Value of Elecsys Blood Test". Basel. 2014-12-10
Novacyt S.A.. (12/8/14). "Press Release: Novacyt Announces a €3.1m Capital Raise and Prepares for New Market Launches". Paris & Cambridge. 2014-12-08
Alizé Pharma S.A.S.. (12/3/14). "Press Release: Alizé Pharma Acquires Exclusive Worldwide Rights on a New Peptide to Tackle Bone Diseases". Lyon. 2014-12-03
Evotec AG. (12/2/14). "Press Release: Evotec and Sanofi Enter Into Exclusive Negotiations for a Major Multi-component Strategic Collaboration. Expect to Sign the Transaction in H1 2015". Hamburg. 2014-12-02
Sanofi S.A.. (12/2/14). "Press Release: Sanofi Receives FDA Approval of Priftin (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection". Paris. 2014-12-02
IntegraGen S.A.. (12/2/14). "Press Release: IntegraGen Obtains Exclusive Worldwide License for Two Molecular Signatures for Patients with Liver Cancer". Evry. 2014-12-02
Vaxon Biotech S.A.. (12/1/14). "Press Release: Vaxon Biotech Randomizes the 110th Patient in Its Oncology Vaccine Phase IIB Clinical Study in NSCLC. Oncology Vaccine Vx-001 Is the Only One in the World to Use Optimized Cryptic Peptides". Paris. 2014-12-01
Accovion GmbH. (12/1/14). "Press Release: Accovion Launches New Subsidiary in France". Frankfurt & Eschborn. 2014-12-01
GamaMabs Pharma S.A.. (11/27/14). "Press Release: GamaMabs Pharma Signs a Collaboration Agreement with Mayo Clinic". Toulouse. 2014-11-27
Neovacs S.A.. (11/24/14). "Press Release: Neovacs Granted 1 Million Europe in Research Tax Credit". Paris. 2014-11-24
Stallergenes S.A.. (11/20/14). "Press Release: Stallergenes and ActoGenix to Develop an Innovative New Class of Oral Allergy Treatments". Antony & Ghent. 2014-11-20
bioMérieux S.A.. (11/18/14). "Press Release: bioMérieux and Illumina Enter Agreement to Co-Develop a Next-generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections". Marcy l’Étoile & San Diego, CA. 2014-11-18
Sofimac Partners. (11/17/14). "Communiqué de Presse: Theranexus Lève avec Succès 3,6 M€ en Amorçage". 2014-11-17
Novasep S.A.. (11/13/14). "Press Release: Novasep and Partner Nilsan Nishotech to Install the First Continuous Chromatography System at Laurus Labs". Pompey. 2014-11-13
Enterome Bioscience S.A.. (11/12/14). "Press Release: Enterome Enters into a Microbiome-based Development Collaboration with AbbVie in Crohn’s Disease". Paris. 2014-11-12
Servier. (11/12/14). "Press Release: Intarcia and Servier Sign Ex-U.S. Partnership for ITCA 650 in Diabetes, Intarcia Retains Independence and Full Control of the U.S. and Japan". Boston, MA. 2014-11-12
Diaxonhit S.A.. (11/12/14). "Press Release: Renewal of Commercial Partnership with One Lambda, Inc. for Diagnostic Tests in Transplantation". Paris. 2014-11-12
Cellectis S.A.. (11/12/14). "Press Release: Cellectis Received Proceeds of €13 Million through the Exercise of Warrants". Paris. 2014-11-12
Valneva S.E.. (11/6/14). "Press Release: Valneva Announces Best Quarterly Results Since Vivalis/Intercell Merger, Meets Business Objectives amd Reconfirms Full Year Outlook". Lyon. 2014-11-06
Carlina Technologies. (11/4/14). "Press Release: Carlina Technologies Signs a Partnership Agreement with Genbiotech to Develop a Sustained-release Protein Formulation for Cartilage Repair". Angers. 2014-11-04
Abivax S.A.. (10/30/14). "Press Release: Abivax Strengthens Executive Management Team with Senior Appointments Karl Birthistle, M.D., Appointed VP of Global Regulatory Affairs Daniel Kenny Appointed Chief Commercial Officer & VP of Business Development". 2014-10-30
Novacyt S.A.. (10/30/14). "Press Release: Novacyt Announces 2014 Half Year Results and Updates Strong Progress with Integration of Lab21". Paris & Cambridge. 2014-10-30
Polyplus-transfection S.A.. (10/28/14). "Press Release: Polyplus-transfection and Blue Sky BioServices Sign a Research and Commercial License Agreement for Use of PEI-based Transfection Technologies". Strasbourg. 2014-10-28
bioMérieux S.A.. (10/22/14). "Press Release: Business Review for the Nine Months Ended September 30, 2014". Marcy l’Étoile. 2014-10-22
Transgene S.A.. (10/21/14). "Press Release: Transgene Announces Third Quarter 2014 Financial Results". Strasbourg. 2014-10-21
bioMérieux S.A.. (10/10/14). "Press Release: bioMérieux Inaugurates a New Multidisciplinary R&D Center for Infectious Disease Diagnostics". Marcy l’Étoile. 2014-10-10
Novasep S.A.. (10/2/14). "Press Release: Novasep to Sell Its Bahamian Plant to Local Investor". Pompey. 2014-10-02
VitamFero S.A.. (9/30/14). "Press Release: VitamFero Successfully Secures Its Third Round of Financing". 2014-09-30
Bionomics Ltd.. (9/23/14). "Press Release: Bionomics Acquires Prestwick Chemical. Pre-existing Business Integration and Strong Synergies". 2014-09-23
Vexim S.A.. (9/22/14). "Press Release: Vexim Announces Strong 2014 Half-year Results". Toulouse. 2014-09-22
bioMérieux S.A.. (9/18/14). "Press Release: bioMérieux Launches chromID Salmonella Elite, the New Generation of Culture Media for Earlier Detection of Salmonella Strains in Clinical Fecal Smaples". Marcy l’Étoile. 2014-09-18
Innate Pharma S.A.. (9/17/14). "Press Release: First Half of 2014 – Broadened Clinical Portfolio and Strengthened Cash Position". 2014-09-17
Novacyt S.A.. (9/17/14). "Press Release: Novacyt Appoints Anthony Dyer as Finance Director". Paris & Cambridge. 2014-09-17
Alizé Pharma S.A.S.. (9/10/14). "Press Release: Alizé Pharma Raises EUR 5 Million (USD 6.6 Million) from Bpifrance/InnoBio and Its Existing Shareholders". Lyon. 2014-09-10
Poxel S.A.. (9/9/14). "Press Release: Poxel Raises EUR10 Million from New Investors to Progress Clinical Development of Two Novel Type 2 Diabetes Therapies". Lyon. 2014-09-09
Vexim S.A.. (9/8/14). "Press Release: Vexim Opens U.S. Subsidiary. Office to Support Vexim’s Product Portfolio Launch in the U.S.". Toulouse. 2014-09-08
Cellectis S.A.. (9/4/14). "Press Release: Cellectis Announces the Closing of the Sale of Its Swedish Subsidiary Cellectis AB to Takara Bio Inc.". Paris. 2014-09-04
bioMérieux S.A.. (9/3/14). "Press Release: First-half 2014 Results". Marcy l’Étoile. 2014-09-03
Cepheid. (9/3/14). "Press Release: Cepheid Announces European Release of Xpert TV, a Next-Generation Molecular Test for Rapid and Accurate Identification of Trichomonas vaginalis Infections". Sunnyvale, CA. 2014-09-03
Vygon S.A.. (9/2/14). "Press Release: Vygon Group Buys Medwin". Ecouen. 2014-09-02
Cepheid. (9/2/14). "Press Release: Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection". Sunnyvale, CA. 2014-09-02
Median Technologies S.A.. (8/25/14). "Press Release: Median Technologies Announces a Reserved Capital Increase of €20 Million. Investment Led by New Enterprise Associates (NEA), a Leading US Healthcare Investor". Sophia Antipolis. 2014-08-25
Valneva S.E.. (8/8/14). "Press Release: Valneva Reports H1 2014 Results, Confirms Full Year Outlook, and Provides Business Update". Lyon. 2014-08-08
Cellectis S.A.. (7/31/14). "Press Release: Pfizer’s Stake in Cellectis’ Capital Is Welcomed by Its Shareholders". Paris. 2014-07-31
Cellectis S.A.. (7/29/14). "Press Release: Cellectis Sells Its Swedish Subsidiary, Cellectis AB, to the Japanese Company Takara Bio Inc.". Paris. 2014-07-29
bioMérieux, Inc.. (7/23/14). "Press Release: bioMérieux Virtuo, the New Generation of Blood Culture System, Is CE-marked". Marcy l’Étoile. 2014-07-23
Novasep S.A.. (7/22/14). "Press Release: Novasep Passes FDA Inspections on Two Sites. Novasep Wins Approval to Produce New Molecular Entity for US Market". Pompey. 2014-07-22
bioMérieux S.A.. (7/17/14). "Press Release: Second-Quarter 2014 Business Review – Solid Growth in First-half Sales ". Marcy l’Étoile. 2014-07-17
Innate Pharma S.A.. (6/24/14). "Press Release: Innate Pharma Raises 50 Million Euros in a Capital Increase Subscribed by Specialist Institutional Investors [Not for Canada, Australia or Japan]". Marseille. 2014-06-24
Innate Pharma S.A.. (6/19/14). "Press Release: Innate Pharma Launches a Capital Increase to Raise Up to 15% of Current Capital [Not for Canada, Australia or Japan]". Marseille. 2014-06-19
Pfizer Inc.. (6/18/14). "Press Release: Pfizer and Cellectis Enter into Global Strategic Cancer Immunotherapy Collaboration". 2014-06-18
Pixium Vision S.A.. (6/17/14). "Press Release: Pixium Vision Raises €34.5 Million (US$ 46.7 Million) in Successful IPO on Euronext Paris, after Full Exercise of the Extension Clause". Paris. 2014-06-17
Prestodiag S.A.S.. (6/10/14). "Press Release: Prestodiag Raises €2.2 Million Euro to Market Its Innovative Solutions for Microbiological Analysis". Paris. 2014-06-10
Cellectis S.A.. (6/5/14). "Press Release: Cellectis and Thermo Fisher Scientific Enter Into Agreements on TALEN, a Leading Gene Editing Technology". Carlsbad, CA & Paris. 2014-06-05
Provence Technologies. (6/2/14). "Press Release: Provence Technologies Acquires Synprosis". Marseille. 2014-06-02
bioMérieux S.A.. (5/28/14). "Press Release: The General Shareholders’ Meeting of bioMérieux Approves the Appointment of Two New Independent Directors". Marcy l’Étoile. 2014-05-28
Lysogene. (5/21/14). "Press Release: Lysogene Raises a 16.5 M€ Series A Led by Sofinnova Partners and Co-led by Innobio and Novo Seeds". Paris. 2014-05-21
Biovision (Fondation pour l’Universite de Lyon / Andrew Lloyd & Associates). (5/19/14). "Press Release: Biovision Presents Its Selection of 44 Promising Life Sciences Businesses and Projects". Lyon. 2014-05-19
Enterome Bioscience S.A.. (5/1/14). "Press Release: Enterome Raises €10 Million in Series B Fund Raising". Paris. 2014-05-01
Sartorius AG. (4/28/14). "Press Release: Sartorius Stedim Biotech Acquires Majority Stake in U.S. Start-up AllPure Technologies. Takeover Extends Sartorius Stedim Biotech Portfolio for Single-use Bioprocessing". Aubagne. 2014-04-28
Sartorius AG. (4/28/14). "Press Release: First-quarter Figures – Sartorius Stedim Biotech Off to a Good Start in 2014". 2014-04-28
bioMérieux S.A.. (4/23/14). "Press Release: First-quarter 2014 Business Review". Marcy l’Étoile. 2014-04-23
Transgene S.A.. (4/22/14). "Press Release: Transgene Reports First Quarter 2014 Financial Results. Circa € 100 Million in Cash as of March 31". Strasbourg. 2014-04-22
BioAlliance Pharma S.A.. (4/16/14). "Press Release: BioAlliance Pharma and Topotarget Enter into Merger Agreement to Create a Leading Orphan Oncology Company". Paris & Copenhagen. 2014-04-16
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top